$REPH Recro Pharma, Inc. Insider Trading Week 18/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Recro Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Recro Pharma, Inc. in week 18/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 08 2018 | REPH | Recro Pharma, Inc. | ALTOMARI ALFRED | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | ALTOMARI ALFRED | Director | Grant | A | 0.00 | 6,183 | 0 | 7,683 | 1.5 K to 7.7 K (+412.20 %) |
| May 08 2018 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |
| May 08 2018 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Grant | A | 0.00 | 6,183 | 0 | 6,983 | 800 to 7 K (+772.88 %) |
| May 08 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |
| May 08 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |
| May 08 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 6,183 | 0 | 13,183 | 7 K to 13.2 K (+88.33 %) |
| May 08 2018 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |